- Condition: Healthy
Interventions: Drug: theophylline; Drug: colchicine
Sponsors: Mutual Pharmaceutical Company, Inc.; Mutual Pharmaceutical Company, Inc.
Not yet recruiting - verified May 2012 - Condition: Morbid Obesity
Interventions: Drug: Ephedrine sulfate with caffeine; Drug: cellulose
Sponsors: Oregon Weight Loss Surgery, LLC; Oregon Weight Loss Surgery, LLC
Not yet recruiting - verified May 2012 - Conditions: Pain, Postoperative; Postoperative Nausea and Vomiting
Interventions: Drug: Tumescent solution with dilute lidocaine and epinephrine; Drug: Tumescent Solution with dilute epinephrine
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Not yet recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: PT003; Drug: PT001; Drug: PT005; Drug: Tiotropium inhalation powder
Sponsors: Pearl Therapeutics, Inc.; Pearl Therapeutics, Inc.
Recruiting - verified April 2012 - Conditions: Emphysema; Poor Sleep Quality
Interventions: Drug: Budesonide/formoterol 160/4.5 mcg; Drug: Placebo
Sponsors: Temple University; Temple University
Recruiting - verified May 2012 - Condition: Stress Urinary Incontinence
Interventions: Drug: Bupivicaine + epinephrine; Drug: Sodium chloride + epinephrine
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Albuterol 25 mcg, Placebo; Drug: Albuterol 0.25 mcg; Drug: Albuterol 90 mcg, Placebo; Drug: Albuterol, 90 mcg; Drug: Placebo; Drug: Proventil 90 mcg; Drug: Proventil 90 mcg
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4; Other: Placebo DPI; Drug: Flovent Diskus 250 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Not yet recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF; Drug: FF/VI
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Pain
Intervention: Drug: 3% mepivacaine/2% lidocaine with 1:100,000 epinephrine combo
Sponsors: Ohio State University; Ohio State University
Not yet recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: Fluticasone Propionate; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate 100mcg; Drug: Placebo; Drug: Vilanterol
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified April 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease; Obstructive Sleep Apnea
Intervention: Drug: Inhaled Fluticasone Propionate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: Tiotropium; Drug: Tiotropium; Drug: Oldaterol; Drug: Tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium; Drug: Olodaterol; Drug: Tiotropium; Drug: tiotropium + olodaterol; Drug: Olodaterol; Drug: Olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Postoperative Pain; Paracervical Block; Laparoscopic Gynecologic Surgery
Interventions: Drug: Bupivacaine with epinephrine; Drug: Normal Saline
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine
Recruiting - verified February 2012 - Conditions: Blood Transfusion; Endothelial Physiopathology; Inflammation; Hemoglobins; Nitric Oxide
Interventions: Procedure: Red blood Cells auto-transfusion; Procedure: Red blood Cells auto-transfusion; Drug: Inhaled Nitric Oxide (iNO) administration
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium+olodaterol; Drug: tiotropium + olodaterol (high dose); Drug: placebo to tiotropium+olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: High Altitude Pulmonary Hypertension
Interventions: Drug: Aminophylline; Drug: Ambrisentan; Drug: Aminophylline plus ambrisentan
Sponsors: Duke University; Duke University
Recruiting - verified March 2012 - Condition: Colic
Intervention: Drug: Nepadutant
Sponsors: Menarini Group; Menarini Group
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Fluticasone, Budesonide, Beclomethasone; Drug: Fluticasone, Beclomethasone, Budesonide; Drug: Budesonide, Fluticasone, Beclomethasone; Drug: Budesonide, Beclomethasone, Fluticasone; Drug: Beclomethasone, Fluticasone, Budesonide; Drug: Beclomethasone, Budesonide, Fluticasone
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: RNS60; Drug: Normal Saline; Drug: Budesonide
Sponsors: Revalesio Corporation; Revalesio Corporation
Not yet recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Nebulized magnesium sulfate
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified September 2011 - Conditions: Neonatal Neurobehavior; Breastfeeding Outcomes
Interventions: Drug: Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour 0.25% bupivacaine and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine/ epinephrine 1:600,000;infusion 10mL/hour 0.25% bupivacaine, 2 mcg/mL fentanyl, and epinephrine 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 10mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 2.5 mcg/mL fentanyl, and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 5 mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 3.5 mcg/mL fentanyl, and epi 1:800,000; Drug: No epidural fentanyl or bupivacaine
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Not yet recruiting - verified April 2012 - Condition: Ulcerative Colitis
Interventions: Drug: Budesonide; Drug: Placebo; Procedure: Procedure/Surgery: Blood sampling, endoscopy
Sponsors: Santarus; Santarus
Recruiting - verified May 2012 - Condition: Bronchiolitis
Interventions: Drug: 3% sodium chloride; Drug: 0.9% sodium chloride
Sponsors: Montefiore Medical Center; Montefiore Medical Center
Recruiting - verified December 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: Placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Flovent Diskus; Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; PPD
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg; Drug: ADVAIR 250/50mcg; Drug: ADVAIR 500/50mcg; Drug: FLOVENT 100mcg; Drug: FLOVENT 250mcg; Drug: FLOVENT 500mcg
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Parexel
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Primatene Mist; Drug: Epinephrine inhalation aerosol, HFA; Drug: epinephrine inhalation aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg; Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg; Drug: Mometasone Furoate MDI 100 mcg; Drug: Mometasone Furoate MDI 200 mcg; Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI; Drug: Prednisone/prednisolone
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg; Drug: ADVAIR 250/50mcg; Drug: FLOVENT 100mcg; Drug: FLOVENT 250mcg
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Parexel
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Drug: Budesonide
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: Asthma
Intervention: Drug: Epinephrine Inhalation Aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified October 2011 - Condition: Crohn's Disease
Intervention: Drug: Entocort
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension
Interventions: Drug: Nitric Oxide; Other: Placebo; Drug: Nitric Oxide
Sponsors: INO Therapeutics; INO Therapeutics
Recruiting - verified May 2012 - Condition: Crohn's Disease
Intervention: Drug: Entocort
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Symbicort pMDI; Drug: Symbicort pMDI; Drug: budesonide pMDI; Drug: budesonide pMDI
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Congestive Heart Failure
Interventions: Drug: Oral R,R'-Fenoterol; Drug: Oral Racemic Fenoterol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Aging (NIA)
Recruiting - verified March 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Formoterol Fumarate; Drug: placebo
Sponsors: Forest Laboratories; Forest Laboratories; Almirall, S.A.
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Fluticasone propionate 100mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Activity/Exercise Induced Bronchospasm
Interventions: Drug: Fluticasone Furoate/Vilanterol Inhalation Powder; Drug: Fluticasone Propionate Inhalation Powder
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone Diskus
Sponsors: Johns Hopkins University; Johns Hopkins University; American Lung Association; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Biological: Omalizumab; Drug: Fluticasone; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Uterine Cervical Dysplasia
Intervention: Drug: sodium bicarbonate buffered lidocaine
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tetrahydrobiopterin (BH4); Drug: non-acetylated salicylate; Dietary Supplement: High Fat Meal; Drug: L-NMMA; Dietary Supplement: Antioxidant Cocktail
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University; American Heart Association
Recruiting - verified July 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: arformoterol; Drug: salmeterol
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center; Sunovion
Recruiting - verified March 2012 - Condition: Lung Cancer
Interventions: Procedure: Nitric oxide breath test; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Flovent Diskus, Advair Diskus, Ventolin HFA, cetirizine, Flonase Nasal Spray, Singulair
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Conditions: Chronic Obstructive Pulmonary Disease; COPD; Emphysema; Chronic Bronchitis
Interventions: Drug: Nebulized arformoterol; Drug: Salmeterol
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified June 2011 - Conditions: Proctitis; Proctosigmoiditis
Intervention: Drug: Budesonide Foam
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Condition: Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson (Lexiscan ®).
Interventions: Drug: Aminophylline; Drug: Placebo
Sponsors: Rush University Medical Center; Rush University Medical Center; John H. Stroger Hospital
Recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone Furoate/Vilanterol; Drug: Vilanterol; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Bronchiolitis Obliterans
Interventions: Drug: fluticasone propionate; Drug: montelukast sodium; Procedure: pulmonary function testing; Other: questionnaire administration; Procedure: quality-of-life assessment; Other: laboratory biomarker analysis; Genetic: protein analysis; Drug: azithromycin
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Perennial Allergic Rhinitis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: University of Chicago; University of Chicago; MedInvent, LLC
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: Tiotropium; Drug: Salmeterol; Drug: Formoterol
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Olmsted Medical Center; American Academy of Family Physicians National Research Network; Harvard Clinical Research Institute
Recruiting - verified March 2012 - Conditions: Pulmonary Arterial Hypertension (PAH); Pulmonary Hypertension-Idiopathic Pulmonary Fibrosis (PH-IPF)
Interventions: Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide
Sponsors: Geno LLC; Geno LLC
Recruiting - verified April 2012 - Condition: Infantile Colic
Interventions: Drug: Nepadutant oral solution; Drug: Nepadutant oral solution; Drug: Placebo matching Nepadutant oral solution
Sponsors: Menarini Group; Menarini Group
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: tiotropium Respimat low dose; Drug: tiotropium Respimat high dose; Drug: placebo Respimat
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified May 2012 - Condition: Acute Kidney Injury
Interventions: Drug: Aminophylline; Drug: Placebo
Sponsors: Stanford University; Stanford University
Recruiting - verified June 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Budesonide+ ipratropium/albuterol; Drug: budesonide/formoterol plus ipratropium/albuterol; Drug: Ipratropium/albuterol
Sponsors: National Jewish Health; National Jewish Health; AstraZeneca
Recruiting - verified April 2012 - Condition: Bronchiolitis
Intervention:
Sponsors: Connecticut Children's Medical Center; Connecticut Children's Medical Center
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: budesonide/formoterol or fluticasone/salmeterol; Drug: budesonide/formoterol or fluticasone/salmeterol
Sponsors: Gelb, Arthur F., M.D.; Gelb, Arthur F., M.D.
Recruiting - verified August 2011 - Conditions: Prematurity; Low Birth Weight
Interventions: Drug: Inhaled Nitric Oxide; Other: Nitrogen
Sponsors: University of Oklahoma; Kris Sekar; Ikaria Holdings Inc.
Recruiting - verified April 2012 - Conditions: Methamphetamine-dependence; Substance Abuse
Interventions: Drug: Ibudilast; Drug: Ibudilast; Drug: Ibudilast
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Institute on Drug Abuse (NIDA); MediciNova
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Intervention: Drug: Formoterol
Sponsors: Yale University; Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: budesonide; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Condition: Endothelial Dysfunction
Interventions: Drug: Trimethaphan; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: fluticasone propionate and salmeterol; Drug: budesonide and formoterol
Sponsors: National Jewish Health; National Jewish Health
Recruiting - verified July 2011 - Conditions: Isoproterenol; Bispectral Index (BIS); Electrophysiology Studies (EPS)
Intervention: Drug: Isoproterenol
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified April 2012 - Condition: Obstructive Sleep Apnea
Interventions: Drug: budesonide nasal spray and a montelukast pill; Drug: Placebo: sugar pill and salt water nasal spray
Sponsors: Romaker & Associates; Romaker & Associates; Merck; AstraZeneca
Recruiting - verified July 2011 - Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaCondition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified June 2011 - Conditions: Fatigue; Aging
Interventions: Drug: Sildenafil placebo; Drug: Sildenafil
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston
Recruiting - verified July 2011 - Conditions: Hypertension; Pure Autonomic Failure; Multiple System Atrophy
Interventions: Drug: Placebo; Drug: Nebivolol 5 mg; Drug: metoprolol tartrate 50 mg; Drug: Sildenafil25 mg
Sponsors: Vanderbilt University; Vanderbilt University; Forest Laboratories
Recruiting - verified May 2012 - Condition: Bronchopulmonary Dysplasia
Intervention: Drug: Infasurf surfactant (ONY, Inc.)
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Conditions: Proctitis; Proctosigmoiditis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Conditions: Proctitis; Proctosigmoiditis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Condition: Hyperglycemia
Interventions: Drug: 5% dextrose; Drug: vitamin C; Drug: Simvastatin; Drug: L-NMMA
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Conditions: Pulmonary Hypertension; Neonatal Hypoxic Respiratory Failure; Persistent Pulmonary Hypertension of Newborn; Congenital Heart Defects; Acute Respiratory Distress Syndrome
Interventions: Drug: Iloprost; Drug: Placebo
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital; Actelion
Recruiting - verified July 2011 - Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Inhaled Nitric Oxide (iNO); Drug: Nitrogen (placebo)
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 2012 - Condition: Amblyopia
Interventions: Drug: Atropine; Device: Plano lens; Drug: Atropine
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Henry Ford Health System; Henry Ford Health System
Recruiting - verified May 2010 - Conditions: Anaphylaxis; Hypotension; Bronchospasm; Angioedema
Interventions: Drug: Epinephrine; Procedure: Bone Marrow Apsiration; Drug: Omalizumab (Xolair)
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2011 - Conditions: Gastrointestinal Disease; Esophageal Cancer; Lung Cancer
Interventions: Procedure: Breathing Test; Behavioral: Respiratory Symptoms Questionnaire; Procedure: Pet Scan
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Levalbuterol; Drug: Levalbuterol UDV TID; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified February 2012 - Condition: Spinal Cord Injury
Interventions: Drug: extended release beta-2 adrenergic agonist; Drug: placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified October 2011 - Condition: Asthma
Intervention: Drug: salmeterol
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; University of Florida
Recruiting - verified August 2011 - Condition: Asthma
Interventions: Drug: budesonide/formoterol or fluticasone/salmeterol; Drug: budesonide/formoterol or fluticasone/salmeterol
Sponsors: Gelb, Arthur F., M.D.; Gelb, Arthur F., M.D.
Recruiting - verified March 2012 - Conditions: Preeclampsia; Hypotension
Interventions: Drug: Ephedrine; Drug: Phenylephrine
Sponsors: Northwestern University; Northwestern University
Recruiting - verified January 2012 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: OBESITY; HYPERTENSION; PURE AUTONOMIC FAILURE; SHY-DRAGER SYNDROME
Interventions: Drug: Trimethaphan; Drug: Trimethaphan; Drug: Pseudoephedrine
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Sickle Cell Disease
Interventions: Drug: nitric oxide; Drug: oxygen
Sponsors: Children's Hospital Boston; Children's Hospital Boston; FDA Office of Orphan Products Development
Recruiting - verified July 2011
 |
Bronchodilator Clinical Trials |
